Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases

NIH RePORTER · NIH · N01 · $8,881 · view on reporter.nih.gov ↗

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

Key facts

NIH application ID: 10376026
Project number: 272201500005I-P00001-759302000001-1
Recipient: DYNPORT VACCINE COMPANY, LLC
Principal Investigator: GRAIG SHOCKEY
Activity code: N01
Funding institute: NIH
Fiscal year: 2021
Award amount: $8,881
Award type: —
Project period: 2019-12-15 → 2020-12-14